Physician profile
Michael Neuwirth
NPI 1699884106
$2,721.47
in general payments reported to CMS, 2019-2025
8 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2022: $53.02 · 2023: $35.26 · 2024: $1,804 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,423 · Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,422.74 |
| Food and Beverage | $755.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,715.11 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $315.34 | 2019-2025 | Embold Fibered, General - Thrombectomy, Therasphere Y90 Glass Microspheres 10 Gbq |
| Stryker Corporation | $276.29 | 2025 | Mild Device Kit, Optablate, Artix Mt |
| Medtronic Vascular, INC. | $261.21 | 2019 | |
| Ge Healthcare | $86.87 | 2019 | |
| Shockwave Medical, INC | $28.73 | 2022 | |
| Avinger INC. | $24.29 | 2022 | |
| Cordis US Corp. | $13.63 | 2025 | Outback |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Neuwirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.